Cardiac problems in the fetus: a review for pediatric providers.
Journal
Current opinion in pediatrics
ISSN: 1531-698X
Titre abrégé: Curr Opin Pediatr
Pays: United States
ID NLM: 9000850
Informations de publication
Date de publication:
01 10 2023
01 10 2023
Historique:
medline:
14
9
2023
pubmed:
19
7
2023
entrez:
19
7
2023
Statut:
ppublish
Résumé
The aim of this study was to provide pediatric providers with a review of the diagnosis and management of fetal cardiac disease in the current era. Prenatal detection of congenital heart disease (CHD) has improved but is still imperfect. In experienced hands, fetal echocardiography can detect severe CHD as early as the first trimester and a majority of more subtle conditions in the second and third trimesters. Beyond detection, a prenatal diagnosis allows for lesion-specific counseling for families as well as for development of a multidisciplinary perinatal management plan, which may involve in-utero treatment. Given the diversity of cardiac diagnoses and the rarity of some, collaborative multicenter fetal cardiac research has gained momentum in recent years. Accurate diagnosis of fetal cardiac disease allows for appropriate counseling, pregnancy and delivery planning, and optimization of immediate neonatal care. There is potential for improving fetal CHD detection rates. Fetal interventions are available for certain conditions, and fetal and pediatric cardiac centers have developed management plans specific to the expected postnatal physiology.
Identifiants
pubmed: 37466056
doi: 10.1097/MOP.0000000000001274
pii: 00008480-990000000-00110
doi:
Types de publication
Review
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
523-530Informations de copyright
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.
Références
Franklin O, Burch M, Manning N, et al. Prenatal diagnosis of coarctation of the aorta improves survival and reduces morbidity. Heart 2002; 87:67–69.
Tworetzky W, McElhinney DB, Reddy VM, et al. Improved surgical outcome after fetal diagnosis of hypoplastic left heart syndrome. Circulation 2001; 103:1269–1273.
Bonnet D, Coltri A, Butera G, et al. Detection of transposition of the great arteries in fetuses reduces neonatal morbidity and mortality. Circulation 1999; 99:916–918.
Holland B, Myers J, Woods C Jr. Prenatal diagnosis of critical congenital heart disease reduces risk of death from cardiovascular compromise prior to planned neonatal cardiac surgery: a meta-analysis. Ultrasound Obstet Gynecol 2015; 45:631–638.
Sethi N, Klugman D, Said M, et al. Standardized delivery room management for neonates with a prenatal diagnosis of congenital heart disease: a model for improving interdisciplinary delivery room care. J Neonatal Perinatal Med 2021; 14:317–329.
Pruetz JD, Wang SS, Noori S. Delivery room emergencies in critical congenital heart diseases. Semin Fetal Neonatal Med 2019; 24:101034.
Donofrio MT, Levy RJ, Schuette JJ, et al. Specialized delivery room planning for fetuses with critical congenital heart disease. Am J Cardiol 2013; 111:737–747.
Friedberg MK, Silverman NH, Moon-Grady AJ, et al. Prenatal detection of congenital heart disease. J Pediatr 2009; 155:26–31. e1.
Liberman RF, Heinke D, Lin AE, et al. Trends in delayed diagnosis of critical congenital heart defects in an era of enhanced screening, 2004–2018. J Pediatr 2023; 257:113366.
Bakker MK, Bergman JEH, Krikov S, et al. Prenatal diagnosis and prevalence of critical congenital heart defects: an international retrospective cohort study. BMJ Open 2019; 9:e028139.
Perez MT, Bucholz E, Asimacopoulos E, et al. Impact of maternal social vulnerability and timing of prenatal care on outcome of prenatally detected congenital heart disease. Ultrasound Obstet Gynecol 2022; 60:346–358.
Krishnan A, Jacobs MB, Morris SA, et al. Impact of socioeconomic status, race and ethnicity, and geography on prenatal detection of hypoplastic left heart syndrome and transposition of the great arteries. Circulation 2021; 143:2049–2060.
Klein J, Dwyer G, Donofrio MT, Krishnan A. Geographic distribution of congenital heart disease: a single surgical center experience. J Pediatr 2022; 240:117–121.
Arnaout R, Curran L, Zhao Y, et al. An ensemble of neural networks provides expert-level prenatal detection of complex congenital heart disease. Nat Med 2021; 27:882–891.
Wren C, Richmond S, Donaldson L. Temporal variability in birth prevalence of cardiovascular malformations. Heart 2000; 83:414–419.
Futura Publishing Company, Ferencz C. Epidemiology of congenital heart disease: the Baltimore-Washington Infant Study 1981–1989. 1993.
Hoffman J. Incidence of congenital heart disease: I. Postnatal incidence. Pediatr Cardiol 1995; 16:103–113.
Hoffman J. Incidence of congenital heart disease: II. Prenatal incidence. Pediatr Cardiol 1995; 16:155–165.
Donofrio MT, Moon-Grady AJ, Hornberger LK, et al. Diagnosis and treatment of fetal cardiac disease: a scientific statement from the American Heart Association. Circulation 2014; 129:2183–2242.
Medicine AIoUi. AIUM practice parameter for the performance of fetal echocardiography. J Ultrasound Med 2020; 39:E5–E16.
Chen L, Yang T, Chen L, et al. Risk of congenital heart defects in offspring exposed to maternal diabetes mellitus: an updated systematic review and meta-analysis. Arch Gynecol Obstet 2019; 300:1491–1506.
Lisowski L, Verheijen P, Copel J, et al. Congenital heart disease in pregnancies complicated by maternal diabetes mellitus. An international clinical collaboration, literature review, and meta-analysis. Herz 2010; 35:19–26.
Ullmo S, Vial Y, Di Bernardo S, et al. Pathologic ventricular hypertrophy in the offspring of diabetic mothers: a retrospective study. Eur Heart J 2007; 28:1319–1325.
Monda E, Verrillo F, Altobelli I, et al. Natural history of left ventricular hypertrophy in infants of diabetic mothers. Int J Cardiol 2022; 350:77–82.
Chameides L, Truex RC, Vetter V, et al. Association of maternal systemic lupus erythematosus with congenital complete heart block. N Engl J Med 1977; 297:1204–1207.
Keller S, Cohen J, Moon-Grady A, et al. Patterns of endocardial fibroelastosis without atrioventricular block in fetuses exposed to anti-Ro/SSA antibodies. Ultrasound Obstet Gynecol 2023; 62:148–151.
Friedman DM, Kim MY, Copel JA, et al. Utility of cardiac monitoring in fetuses at risk for congenital heart block: the PR Interval and Dexamethasone Evaluation (PRIDE) prospective study. Circulation 2008; 117:485–493.
Buyon JP, Hiebert R, Copel J, et al. Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry. J Am Coll Cardiol 1998; 31:1658–1666.
Scientific Abstracts from the Phoenix Children's 13th Annual Fetal Cardiology Symposium December 8-11, 2022 at The Phoenician, Scottsdale, AZ. Pediatr Cardiol. 2023;44(Suppl 1):1–5.
Cuneo BF, Sonesson SE, Levasseur S, et al. Home monitoring for fetal heart rhythm dDuring Anti-Ro pregnancies. J Am Coll Cardiol 2018; 72:1940–1951.
Drewes BM, Phoon CK, Sinkoveskaya ES, et al. Home monitoring to detect emergent anti-Ro/SSA antibody mediated fetal Av block: preliminary results of the STOP BLOQ Study. Circulation 2021; 144: (Suppl 1): A9355-A.
Galdini A, Fesslova VM, Gaeta G, et al. Prevalence of congenital heart defects in pregnancies conceived by assisted reproductive technology: a cohort study. J Clin Med 2021; 10:5363.
Giorgione V, Parazzini F, Fesslova V, et al. Congenital heart defects in IVF/ICSI pregnancy: systematic review and meta-analysis. Ultrasound Obstet Gynecol 2018; 51:33–42.
Bahtiyar MO, Campbell K, Dulay AT, et al. Is the rate of congenital heart defects detected by fetal echocardiography among pregnancies conceived by in vitro fertilization really increased? A case–historical control study. J Ultrasound Med 2010; 29:917–922.
Øyen N, Boyd HA, Carstensen L, et al. Risk of congenital heart defects in offspring of affected mothers and fathers. Circ Genom Precis Med 2022; 15:e003533.
Kelle AM, Qureshi MY, Olson TM, et al. Familial incidence of cardiovascular malformations in hypoplastic left heart syndrome. Am J Cardiol 2015; 116:1762–1766.
Lewin MB, McBride KL, Pignatelli R, et al. Echocardiographic evaluation of asymptomatic parental and sibling cardiovascular anomalies associated with congenital left ventricular outflow tract lesions. Pediatrics 2004; 114:691–696.
Parker LE, Landstrom AP. Genetic etiology of left-sided obstructive heart lesions: a story in development. J Am Heart Assoc 2021; 10:e019006.
McBride KL, Pignatelli R, Lewin M, et al. Inheritance analysis of congenital left ventricular outflow tract obstruction malformations: segregation, multiplex relative risk, and heritability. Am J Med Genet A 2005; 134:180–186.
Barris DM, Brailovschi Y, Shah A, et al. The role of fetal echocardiogram after detection of extracardiac anomalies in utero (fetal echocardiogram for extracardiac malformations). Prenat Diagn 2021; 41:1134–1139.
Lin AE, Santoro S, High FA, et al. Congenital heart defects associated with aneuploidy syndromes: new insights into familiar associations. Am J Med Genet C Semin Med Genet 2020; 184:53–63.
Wang H, Lin X, Lyu G, et al. Chromosomal abnormalities in fetuses with congenital heart disease: a meta-analysis. Arch Gynecol Obstet 2023; doi: 10.1007/s00404-023-06910-3. [Epub ahead of print].
doi: 10.1007/s00404-023-06910-3.
Pierpont Mary E, Brueckner M, Chung Wendy K, et al. Genetic basis for congenital heart disease: revisited: a scientific statement from the American Heart Association. Circulation 2018; 138:e653–e711.
Bravo-Valenzuela NJ, Rocha LA, Nardozza LMM, Júnior EA. Fetal cardiac arrhythmias: current evidence. Ann Pediatr Cardiol 2018; 11:148–163.
Springett A, Wellesley D, Greenlees R, et al. Congenital anomalies associated with trisomy 18 or trisomy 13: a registry-based study in 16 European countries, 2000–2011. Am J Med Genet A 2015; 167:3062–3069.
Makrydimas G, Sotiriadis A, Huggon IC, et al. Nuchal translucency and fetal cardiac defects: a pooled analysis of major fetal echocardiography centers. Am J Obstet Gynecol 2005; 192:89–95.
Atzei A, Gajewska K, Huggon I, et al. Relationship between nuchal translucency thickness and prevalence of major cardiac defects in fetuses with normal karyotype. Ultrasound Obstet Gynecol 2005; 26:154–157.
Prefumo F, Güven M, Carvalho J. Single umbilical artery and congenital heart disease in selected and unselected populations. Ultrasound Obstet Gynecol 2010; 35:552–555.
Martínez-Frías ML, Bermejo E, Rodríguez-Pinilla E, et al. Does single umbilical artery (SUA) predict any type of congenital defect? Clinical–epidemiological analysis of a large consecutive series of malformed infants. Am J Med Genet A 2008; 146:15–25.
Pruetz JD, Sklansky M, Detterich J, et al. Twin–twin transfusion syndrome treated with laser surgery: postnatal prevalence of congenital heart disease in surviving recipients and donors. Prenat Diagn 2011; 31:973–977.
Bahtiyar MO, Dulay AT, Weeks BP, et al. Prevalence of congenital heart defects in monochorionic/diamniotic twin gestations: a systematic literature review. J Ultrasound Med 2007; 26:1491–1498.
Boehme C, Fruitman D, Eckersley L, et al. The diagnostic yield of fetal echocardiography indications in the current era. J Am Soc Echocardiogr 2022; 35:217–227. e1.
McBrien A, Hornberger LK. Early fetal echocardiography. Birth Defects Res 2019; 111:370–379.
Yu D, Sui L, Zhang N. Performance of first-trimester fetal echocardiography in diagnosing fetal heart defects: meta-analysis and systematic review. J Ultrasound Med 2020; 39:471–480.
Lee W, Drose J, Wax J, et al. AIUM practice guideline for the performance of fetal echocardiography. J Ultrasound Med 2013; 32:1067–1082.
Behar JA, Bonnemains L, Shulgin V, et al. Noninvasive fetal electrocardiography for the detection of fetal arrhythmias. Prenat Diagn 2019; 39:178–187.
Vasciaveo L, Zanzarelli E, D’Antonio F. Fetal cardiac function evaluation: a review. J Clin Ultrasound 2023; 51:215–224.
Mozumdar N, Rowland J, Pan S, et al. Diagnostic accuracy of fetal echocardiography in congenital heart disease. J Am Soc Echocardiogr 2020; 33:1384–1390.
Behera SK, Ding VY, Chung S, Tacy TA. Impact of fetal echocardiography comprehensiveness on diagnostic accuracy. J Am Soc Echocardiogr 2022; 35:752–761. e11.
Haberer K, He R, McBrien A, et al. Accuracy of fetal echocardiography in defining anatomic details: a single-institution experience over a 12-year period. J Am Soc Echocardiogr 2022; 35:762–772.
Szwast A, Tian Z, McCann M, et al. Vasoreactive response to maternal hyperoxygenation in the fetus with hypoplastic left heart syndrome. Circ Cardiovasc Imaging 2010; 3:172–178.
Schidlow DN, Donofrio MT. Prenatal maternal hyperoxygenation testing and implications for critical care delivery planning among fetuses with congenital heart disease: early experience. Am J Perinat 2018; 35:16–23.
Patel SR, Madan N, Jone PN, Donofrio MT. Utility of fetal echocardiography with acute maternal hyperoxygenation testing in assessment of complex congenital heart defects. Children (Basel) 2023; 10:281.
Lee CK. Prenatal counseling of fetal congenital heart disease. Curr Treat Options Cardiovasc Med 2017; 19:1–14.
Kovacevic A, Elsässer M, Fluhr H, et al. Counseling for fetal heart disease: current standards and best practice. Transl Pediatr 2021; 10:2225.
Allan LD, Huggon IC. Counselling following a diagnosis of congenital heart disease. Prenat Diagn 2004; 24:1136–1142.
Walsh MJ, Verghese GR, Ferguson ME, et al. Counseling practices for fetal hypoplastic left heart syndrome. Pediatr Cardiol 2017; 38:946–958.
Keelan JA, Moon Grady AJ, Arya B, et al. Current state of fetal heart disease counseling and training: room for improvement? Endorsed by the Fetal Heart Society. Pediatr Cardiol 2022; 43:1548–1558.
Rychik J, Donaghue DD, Levy S, et al. Maternal psychological stress after prenatal diagnosis of congenital heart disease. J Pediatr 2013; 162:302–307. e1.
Brosig CL, Whitstone BN, Frommelt MA, et al. Psychological distress in parents of children with severe congenital heart disease: the impact of prenatal versus postnatal diagnosis. J Perinatol 2007; 27:687–692.
Mangin-Heimos KS, Strube M, Taylor K, et al. Trajectories of maternal and paternal psychological distress after fetal diagnosis of moderate–severe congenital heart disease. J Pediatr Psychol 2022; 48:305–316.
Alder J, Fink N, Bitzer J, et al. Depression and anxiety during pregnancy: a risk factor for obstetric, fetal and neonatal outcome? A critical review of the literature. J Matern Fetal Neonatal Med 2007; 20:189–209.
Maina G, Saracco P, Giolito MR, et al. Impact of maternal psychological distress on fetal weight, prematurity and intrauterine growth retardation. J Affect Disord 2008; 111:214–220.
Hilton-Kamm D, Sklansky M, Chang RK. How not to tell parents about their child's new diagnosis of congenital heart disease: an Internet survey of 841 parents. Pediatr Cardiol 2014; 35:239–252.
Tacy TA, Kasparian NA, Karnik R, et al. Opportunities to enhance parental well being during prenatal counseling for congenital heart disease. Semin Perinatol 2022; 46:151587.
Harris KW, Hammack-Aviran CM, Brelsford KM, et al. Mapping parents’ journey following prenatal diagnosis of CHD: a qualitative study. Cardiol Young 2022; 1–9.
Bratt E-L, Järvholm S, Ekman-Joelsson B-M, et al. Parental reactions, distress, and sense of coherence after prenatal versus postnatal diagnosis of complex congenital heart disease. Cardiol Young 2019; 29:1328–1334.
Wacker-Gussmann A, Strasburger JF, Cuneo BF, Wakai RT. Diagnosis and treatment of fetal arrhythmia. Am J Perinatol 2014; 31:617–628.
Miyoshi T, Maeno Y, Hamasaki T, et al. Antenatal therapy for fetal supraventricular tachyarrhythmias: multicenter trial. J Am Coll Cardiol 2019; 74:874–885.
Donofrio MT, Moon-Grady AJ, Hornberger LK, et al. Diagnosis and treatment of fetal cardiac disease. Circulation 2014; 129:2183–2242.
Bravo-Valenzuela NJ, Rocha LA, Machado Nardozza LM, Araujo Júnior E. Fetal cardiac arrhythmias: current evidence. Ann Pediatr Cardiol 2018; 11:148–163.
O’Leary ET, Alexander ME, Bezzerides VJ, et al. Low mortality in fetal supraventricular tachycardia: outcomes in a 30-year single-institution experience. J Cardiovasc Electrophysiol 2020; 31:1105–1113.
Barnes BT, Procaccini D, Crino J, et al. Maternal sirolimus therapy for fetal cardiac rhabdomyomas. N Engl J Med 2018; 378:1844–1845.
Breathnach C, Pears J, Franklin O, et al. Rapid regression of left ventricular outflow tract rhabdomyoma after sirolimus therapy. Pediatrics 2014; 134:e1199–e1202.
Ebrahimi-Fakhari D, Stires G, Hahn E, et al. Prenatal sirolimus treatment for rhabdomyomas in tuberous sclerosis. Pediatr Neurol 2021; 125:26–31.
Park H, Chang CS, Choi SJ, et al. Sirolimus therapy for fetal cardiac rhabdomyoma in a pregnant woman with tuberous sclerosis. Obstet Gynecol Sci 2019; 62:280–284.
Patel C, Abraham S, Ferdman D. Rapid regression of prenatally identified intrapericardial giant rhabdomyomas with sirolimus. CASE (Phila) 2018; 2:258–261.
Pluym ID, Sklansky M, Wu JY, et al. Fetal cardiac rhabdomyomas treated with maternal sirolimus. Prenat Diagn 2020; 40:358–364.
Will JC, Siedentopf N, Schmid O, et al. Successful prenatal treatment of cardiac rhabdomyoma in a fetus with tuberous sclerosis. Pediatr Rep 2023; 15:245–253.
Edwards LA, Lara DA, Sanz Cortes M, et al. Chronic maternal hyperoxygenation and effect on cerebral and placental vasoregulation and neurodevelopment in fetuses with left heart hypoplasia. Fetal Diagn Ther 2019; 46:45–57.
Lara DA, Morris SA, Maskatia SA, et al. Pilot study of chronic maternal hyperoxygenation and effect on aortic and mitral valve annular dimensions in fetuses with left heart hypoplasia. Ultrasound Obstet Gynecol 2016; 48:365–372.
Lee FT, Marini D, Seed M, Sun L. Maternal hyperoxygenation in congenital heart disease. Transl Pediatr 2021; 10:2197–2209.
Freud LR, Wilkins-Haug LE, Beroukhim RS, et al. Effect of in utero non-steroidal anti-inflammatory drug therapy for severe Ebstein anomaly or tricuspid valve dysplasia (NSAID Therapy for Fetal Ebstein anomaly). Am J Cardiol 2021; 141:106–112.
Torigoe T, Mawad W, Seed M, et al. Treatment of fetal circular shunt with nonsteroidal anti-inflammatory drugs. Ultrasound Obstet Gynecol 2019; 53:841–846.
Freud LR, McElhinney DB, Marshall AC, et al. Fetal aortic valvuloplasty for evolving hypoplastic left heart syndrome: postnatal outcomes of the first 100 patients. Circulation 2014; 130:638–645.
Friedman KG, Sleeper LA, Freud LR, et al. Improved technical success, postnatal outcome and refined predictors of outcome for fetal aortic valvuloplasty. Ultrasound Obstet Gynecol 2018; 52:212–220.
Kovacevic A, Ohman A, Tulzer G, et al. Fetal hemodynamic response to aortic valvuloplasty and postnatal outcome: a European multicenter study. Ultrasound Obstet Gynecol 2018; 52:221–229.
Patel ND, Nageotte S, Ing FF, et al. Procedural, pregnancy, and short-term outcomes after fetal aortic valvuloplasty. Catheter Cardiovasc Interv 2020; 96:626–632.
Pickard SS, Wong JB, Bucholz EM, et al. Fetal aortic valvuloplasty for evolving hypoplastic left heart syndrome: a decision analysis. Circ Cardiovasc Qual Outcomes 2020; 13:e006127.
Jantzen DW, Moon-Grady AJ, Morris SA, et al. Hypoplastic left heart syndrome with intact or restrictive atrial septum: a report from the International Fetal Cardiac Intervention Registry. Circulation 2017; 136:1346–1349.
Marshall AC, van der Velde ME, Tworetzky W, et al. Creation of an atrial septal defect in utero for fetuses with hypoplastic left heart syndrome and intact or highly restrictive atrial septum. Circulation 2004; 110:253–258.
Hogan WJ, Grinenco S, Armstrong A, et al. Fetal cardiac intervention for pulmonary atresia with intact ventricular septum: International Fetal Cardiac Intervention Registry. Fetal Diagn Ther 2020; 1–9.
Tulzer A, Arzt W, Gitter R, et al. Immediate effects and outcome of in-utero pulmonary valvuloplasty in fetuses with pulmonary atresia with intact ventricular septum or critical pulmonary stenosis. Ultrasound Obstet Gynecol 2018; 52:230–237.
Haxel CS, Johnson JN, Hintz S, et al. Care of the fetus with congenital cardiovascular disease: from diagnosis to delivery. Pediatrics 2022; 150: (Suppl 2): e2022056415C.
Sanapo L, Pruetz JD, Słodki M, et al. Fetal echocardiography for planning perinatal and delivery room care of neonates with congenital heart disease. Echocardiography 2017; 34:1804–1821.
Barris DM, Mikhno M, Kornblit M, et al. Clinical utility of repeat fetal echocardiography in congenital heart disease. Ultrasound Obstet Gynecol 2023; doi: 10.1002/uog.26240. [Epub ahead of print].
doi: 10.1002/uog.26240.
Trines J, Hornberger L. Evolution of congenital heart disease in utero. Pediatr Cardiol 2004; 25:287–298.
Yagel S, Weissman A, Rotstein Z, et al. Congenital heart defects: natural course and in utero development. Circulation 1997; 96:550–555.
Donofrio MT. Predicting the future: delivery room planning of congenital heart disease diagnosed by fetal echocardiography. Am J Perinatol 2018; 35:549–552.
Donofrio MT, Skurow-Todd K, Berger JT, et al. Risk-stratified postnatal care of newborns with congenital heart disease determined by fetal echocardiography. J Am Soc Echocardiogr 2015; 28:1339–1349.
Afshar Y, Hogan WJ, Conturie C, et al. Multi-institutional practice-patterns in fetal congenital heart disease following implementation of a Standardized Clinical Assessment and Management Plan. J Am Heart Assoc 2021; 10:e021598.